TY - JOUR
T1 - Surgical outcomes of laparoscopic versus open repeat liver resection for liver cancers
T2 - A report from a nationwide surgical database in Japan
AU - Kaibori, Masaki
AU - Ichihara, Nao
AU - Miyata, Hiroaki
AU - Kakeji, Yoshihiro
AU - Nanashima, Atsushi
AU - Kitagawa, Yuko
AU - Yamaue, Hiroki
AU - Yamamoto, Masakazu
AU - Endo, Itaru
N1 - Funding Information:
This study was supported financially by the Japanese Society of Hepatobiliary and Pancreatic Surgery. The authors thank all of the doctors, data managers, and other hospital staff for participating in the NCD and for their great efforts in accurate data collection. We also would like to thank Enago (www. Enago.jp) for the English language review.
Publisher Copyright:
© 2022 Japanese Society of Hepato-Biliary-Pancreatic Surgery.
PY - 2022/8
Y1 - 2022/8
N2 - Background/Purpose: Laparoscopic (repeat) liver resection (LRLR) is a well-established liver tumor treatment. However, since its outcomes and comparison with open repeat liver resection (ORLR) in recurrent liver cancer remain inadequately studied, this study then aimed to compare their short-term outcomes for liver cancers (hepatocellular carcinoma, intrahepatic cholangiocellular carcinoma, and metastatic liver cancer). Methods: Repeat liver resection cases between 2013 and 2017 from Japan’s National Clinical Database were extracted. We used propensity score matching (PSM) to compare the proportion of patients with postoperative complications of Clavien-Dindo classification grade II or higher (CD2+) (primary endpoint), as well as the operative time, intraoperative bleeding volume, and intraoperative transfusion implementation rate (secondary endpoints). Results: Of 2902 patients (ORLR, 2476; LRLR, 426), 712 (356 per type) with comparable backgrounds remained via PSM. Before and after PSM, the postoperative CD2+ complication rate was significantly lower in the LRLR group, who had shorter operative time, smaller intraoperative bleeding volume, and lower intraoperative transfusion rate, than in the ORLR group (after matching, 7.6% vs 18.3%, P < 0.0001). Conclusions: LRLR showed better short-term outcomes than ORLR, making it a safer and more effective liver cancer treatment.
AB - Background/Purpose: Laparoscopic (repeat) liver resection (LRLR) is a well-established liver tumor treatment. However, since its outcomes and comparison with open repeat liver resection (ORLR) in recurrent liver cancer remain inadequately studied, this study then aimed to compare their short-term outcomes for liver cancers (hepatocellular carcinoma, intrahepatic cholangiocellular carcinoma, and metastatic liver cancer). Methods: Repeat liver resection cases between 2013 and 2017 from Japan’s National Clinical Database were extracted. We used propensity score matching (PSM) to compare the proportion of patients with postoperative complications of Clavien-Dindo classification grade II or higher (CD2+) (primary endpoint), as well as the operative time, intraoperative bleeding volume, and intraoperative transfusion implementation rate (secondary endpoints). Results: Of 2902 patients (ORLR, 2476; LRLR, 426), 712 (356 per type) with comparable backgrounds remained via PSM. Before and after PSM, the postoperative CD2+ complication rate was significantly lower in the LRLR group, who had shorter operative time, smaller intraoperative bleeding volume, and lower intraoperative transfusion rate, than in the ORLR group (after matching, 7.6% vs 18.3%, P < 0.0001). Conclusions: LRLR showed better short-term outcomes than ORLR, making it a safer and more effective liver cancer treatment.
KW - Japanese National Clinical Database
KW - laparoscopic repeat liver resection
KW - national survey
KW - open repeat liver resection
KW - recurrent liver cancers
UR - http://www.scopus.com/inward/record.url?scp=85129650323&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129650323&partnerID=8YFLogxK
U2 - 10.1002/jhbp.1156
DO - 10.1002/jhbp.1156
M3 - Article
C2 - 35445565
AN - SCOPUS:85129650323
SN - 1868-6974
VL - 29
SP - 833
EP - 842
JO - Journal of Hepato-Biliary-Pancreatic Sciences
JF - Journal of Hepato-Biliary-Pancreatic Sciences
IS - 8
ER -